Viral Tropism Profiling

About Systasy Bioscience

Systasy Bioscience is a private German biotech firm that has developed a proprietary, breakthrough DNA barcoding technology for single-cell transcriptomics. Its platform enables highly multiplexed analysis of hundreds of pathological processes simultaneously, aiming to de-risk drug discovery by connecting compound activity to patient-specific data. The company operates as a technology provider and service partner for pharmaceutical companies, focusing on applications in pathway-based drug discovery, human disease models, and viral vector development for gene therapy. Key collaborations with entities like Ono Pharmaceutical and Evogene validate its platform's potential.